Burton JL, Cunliffe WJ, Stafford L, et al. The prevalence of acne vulgaris in adolescence. Br J Dermatol. 1971; 85: 119–26 ArticlePubMedCAS Google Scholar
Goulden V, Stables GI, Cunliffe WJ. The prevalence of facial acne in adults. J Am Acad Dermatol. 1999; 41: 577–80 PubMedCAS Google Scholar
Shafer T, Nienhaus A, Vieluf D, et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol. 2001; 145: 100–4 Article Google Scholar
Goulden V, Clark SM, Cunliffe WJ. Post adolescent acne: a review of clinical features. Br J Dermatol. 1997; 136: 66–70 ArticlePubMedCAS Google Scholar
Marks R. Acne and its management beyond the age of 35 years. Am J Clin Dermatol. 2004; 5 (6): 459–62 ArticlePubMed Google Scholar
Gollnick MD, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003; 49: S I–38 Article Google Scholar
McGeown CH, Goulden V, Holland D, et al. Sebum excretion in post adolescent acne compared to controls and adolescent acne [abstract]. J Invest Dermatol. 1997; 108: 386 Google Scholar
Sheehan-Dare RA, Hughes BR, Cunliffe WJ. Clinical markers of androgenicity in acne vulgaris. Br J Dermatol. 1988 Dec; 119 (6): 723–30 ArticlePubMedCAS Google Scholar
Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004 Sep-Oct; 22 (5): 419–28 ArticlePubMed Google Scholar
Vershoore M. Aspect hormonaux de l’acne. Ann Dermatol Venereol. 1987; 114: 439–54 Google Scholar
Lawrence D, Shaw M, Katz M. Elevated free testosterone concentration in men and women with acne vulgaris. Clin Exp Dermatol. 1986; 11: 263–73 ArticlePubMedCAS Google Scholar
Lucky AW, McGuire J, Rosenfield RL, et al. Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983; 81: 70–4 ArticlePubMedCAS Google Scholar
Pochi PE, Comite H, Longcope C. Hormone blood levels in women with acne [abstract]. J Invest Dermatol. 1986; 86: 501 Google Scholar
Sultan C, Oliel V, Audran F, et al. Free and total plasma testosterone in men and women with acne. Acta Derm Venereol (Stockh). 1986; 66: 301–4 CAS Google Scholar
Lookingbill DP, Horton R, Demers LM, et al. Tissue production of androgens in women with acne. J Am Acad Dermatol. 1985; 12: 481–7 ArticlePubMedCAS Google Scholar
Carmina E, Lobo RA. Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J Clin Endocrinol Metab. 1993; 76: 1111–4 ArticlePubMedCAS Google Scholar
Thiboutot D, Gilliland K, Light J, et al. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol. 1999; 135: 1041–5 ArticlePubMedCAS Google Scholar
Allam SG. Acne vulgaris in the sixth decade and beyond [Master of Science thesis]. Cardiff: University of Wales, 1991 Google Scholar
Eady EA, Gloor M, Lleyden JJ. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003; 206: 54–6 ArticlePubMedCAS Google Scholar
Eady EA, Cove JH, Holland KT, et al. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol. 1989; 121: 51–7 ArticlePubMedCAS Google Scholar
Ozolins M, Eady EA, Avery A, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004; 364: 2188–95 ArticlePubMedCAS Google Scholar
Till AE, Goulden V, Cunliffe WJ, et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol. 2000; 142: 885–92 ArticlePubMedCAS Google Scholar
Layton AM, Seukaran D, Cunliffe WJ. Scarred for life?. Dermatology. 1997; 195: 15–21 ArticlePubMed Google Scholar
Myhill JE, Leichtmen SR, Bumett JW. Self-esteem and social assertiveness in patients receiving isotretinoin treatment for cystic acne. Cutis. 1988; 41: 171–3 Google Scholar
Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998; 134: 454–8 ArticlePubMedCAS Google Scholar
Derman RJ. Androgen excess in women. Int J Fertil Menopausal Stud. 1996 Mar–Apr; 41 (2): 172–6 PubMedCAS Google Scholar
McLaughlin B, Barrett P, Finch T, et al. Late-onset adrenal hyperplasia in a group of Irish females who presented with hirsutism, irregular menses and/or cystic acne. Clin Endocrinol. 1990; 32: 57–64 ArticleCAS Google Scholar
Leyden JJ. Antibiotic resistance in the topical treatment of acne vulgaris. Cutis. 2004 Jun; 73 (6 Suppl.): 6–10 PubMed Google Scholar
Griffiths CEM. Nicotinamide 4% gel for the treatment of inflammatory acne. J Dermatolog Treat. 1995; 6 Suppl. 1: S8–10 Google Scholar
Dreno B, Bettoli V, Ochsendorf F. European recommendations on the use of oral antibiotics for acne. Ear J Dermatol. 2004; 14 (6): 391–9 Google Scholar
Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother. 2005 Mar; 6 (3): 409–18 ArticlePubMedCAS Google Scholar
Shaw JC, White LE. Persistent acne in adult women. Arch Dermatol. 2001; 137: 1252–3 PubMedCAS Google Scholar
DeRossi SS, Hersh EV. Antibiotics and oral contraceptives. Dent Clin North Am. 2002; 46 (4): 653–4 ArticlePubMed Google Scholar
Thiboutot D. Hormones and acne: pathophysiology, clinical evaluation, and therapies. Semin Cutan Med Surg. 2001; 20: 144–53 ArticlePubMedCAS Google Scholar
Huber J, Foidart JM, Wuttke W, et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone. Eur J Contracept Reprod Health Care. 2000; 5: 25–34 ArticlePubMedCAS Google Scholar
Goodfellow A, Alaghband-Zadeh J, Carter G, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol. 1984; 111: 209–14 ArticlePubMedCAS Google Scholar
Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol. 2000; 43: 498–502 ArticlePubMedCAS Google Scholar
Yemisci A, Gorgulu A, Piskin S. Effects and side-effects of spironolactone therapy in women with acne. J Eur Acad Dermatol Venereol. 2005 Mar; 19 (2): 163–6 ArticlePubMedCAS Google Scholar
Cusan L, Dupont A, Belanger A, et al. Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol. 1990; 23: 462–9 ArticlePubMedCAS Google Scholar
Manso G, Thole Z, Salquiero E, et al. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish Pharmacovigilance System. Pharmacoepidemiol Drug Saf. 2006 Apr; 15 (4): 253–9 ArticlePubMedCAS Google Scholar
Shaw JC. Acne: effect of hormones on pathogenesis and management. Am J Clin Dermatol. 2002; 3 (8): 571–8 ArticlePubMed Google Scholar
Ostlere LS, Rumsby G, Holownia P, et al. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol. 1998; 48: 209–15 ArticleCAS Google Scholar
Saihan E, Burton J. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen treatment. Br J Dermatol. 1981; 103: 139–42 Article Google Scholar
Pochi P, Strauss J. Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment. Arch Dermatol. 1976; 112: 1108–9 ArticlePubMedCAS Google Scholar
Cunliffe WJ, van de Kerkhof PC, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology. 1997; 194 (4): 351–7 ArticlePubMedCAS Google Scholar
Committee for Proprietary Medicinal Products (CPMP). Summary information on a referral opinion following an arbitration pursuant to article 30 of directive 2001/83/ED, for Roaccutane and associated names [online]. London: European Agency for the Evaluation of Medicinal Products, 2003. Available from URL: http://www.emea.eu.int/pdfs/human/referral/isotretinoin/281103en.pdf [Accessed 2006 Sep 13] Google Scholar
Committee for Proprietary Medicinal Products (CPMP). Annex III: amended summary of product characteristics of the reference member state [online]. London: European Agency for the Evaluation of Medicinal Products, 2003. Available from URL: http://www.emea.europa.eu/pdfs/human/referral/roaccutane/284603enl.pdf [Accessed 2006 Sep 13] Google Scholar
Committee for Proprietary Medicinal Products (CPMP). Annex II: scientific conclusions and grounds for amendment of the summary(ies) of product characteristics presented by the EMEA [online]. London: European Agency for the Evaluation of Medicinal Products, 2003. Available from URL: http://www.emea.europa.eu/pdfs/human/referral/roaccutane/284603enl.pdf [Accessed 2006 Sep 13] Google Scholar
Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005 Jun; 24 (2): 92–102 ArticlePubMedCAS Google Scholar
Goulden V, Clark SM, McGeown C, et al. Treatment of acne with intermittent isotretinoin. Br J Dermatol. 1997 Jul; 137 (1): 106–8 ArticlePubMedCAS Google Scholar
Zane LT. Acne maintenance therapy: expanding the role of topical retinoids?. Arch Dermatol. 2006 May; 142 (5): 638–40 ArticlePubMed Google Scholar
Goulden V, Clark SM, Cunliffe WJ. Treatment of adult acne with low-dose intermittent isotretinoin [abstract]. Br J Dermatol. 1996; 135: 20 Article Google Scholar
Cunliffe WJ. Treatment of acne. In: Cunliffe WJ, editor. Acne. London: Martin Dunitz Ltd, 1991: 252–87 Google Scholar
Breathnach AS. Melanin hyperpigmentation of skin. Cutis. 1996; 57: 36–45 PubMedCAS Google Scholar
Pepall LM, Cosgrove MP, Cunliffe WJ. Ablation of whiteheads by cautery under topical anaesthetic. Br J Dermatol. 1991; 125: 256–9 ArticlePubMedCAS Google Scholar
Atzori L, Brundu MA, Orru A. Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol. 1999; 12: 119–22 ArticlePubMedCAS Google Scholar